Edition:
United States

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

65.39USD
3:12pm EDT
Change (% chg)

$3.33 (+5.37%)
Prev Close
$62.06
Open
$62.30
Day's High
$66.27
Day's Low
$62.25
Volume
220,681
Avg. Vol
385,783
52-wk High
$73.90
52-wk Low
$14.68

Chart for

About

Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct... (more)

Overall

Beta: --
Market Cap(Mil.): $2,955.31
Shares Outstanding(Mil.): 47.19
Dividend: --
Yield (%): --

Financials

  CRSP.OQ Industry Sector
P/E (TTM): -- 235.76 33.88
EPS (TTM): -1.63 -- --
ROI: -20.70 -5.45 13.21
ROE: -27.25 -6.94 15.18

BRIEF-Crispr Therapeutics Reports Q1 Loss Per Share $0.62

* CRISPR THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 08 2018

BRIEF-Crispr Therapeutics Qtrly ‍​collaboration Revenue $32.3 Mln

* CRISPR THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 08 2018

BRIEF-Crispr Therapeutics Says Public Offering Of 5 Mln Common Shares Priced At $22.75/Share

* CRISPR THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON SHARES

Jan 04 2018

BRIEF-Crispr Therapeutics ‍Commences Public Offering Of $100 Mln Common Shares​

* CRISPR THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES

Jan 03 2018

Competitors

Earnings vs. Estimates